Liver Cancer
Viral hepatitis related cancers prevail because of persistent inflammation
Published in Hepatitis Weekly, November 17th, 2003
"Among seven human hepatitis viruses (A to E, G and TT virus), hepatitis B (HBV) and C (HCV) viruses are able to persist in the host for years and principally contribute to the establishment of chronic hepatitis. During the course of persistent infection, continuous intrahepatic inflammation maintains a cycle of liver cell destruction and regeneration that often terminates in hepatocellular carcinoma (HCC)," scientists writing in the journal Current Molecular Medicine say.
"While the expression and retention of viral proteins in hepatocytes may influence the severity...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-11-17)
More Articles from Hepatitis Weekly
- Cardiology
Hepatitis C virus may play a role in hypertrophic cardiomyopathy formation - Transplantation
Undetected tumors won't change cancer-related liver transplant outcomes - Blood Products
Hemophilia patients in Japan bear a novel subtype of GB virus C hepatitis G - Immunology
HBV gene changes precipitate viral breakthrough after liver transplantation - Kidney Disease
Risk for interferon-related kidney failure warrants close patient management - Cancer Treatment
FDA grants Fast Track Designation for HCC treatment - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
